Journal article · 2023 · Open access
Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study
Arthritis Research & Therapy, 25(1), 129 · Published 26 July 2023 · DOI 10.1186/s13075-023-03111-w
In brief
“Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study” is a 2023 journal article by Se Rim Choi and 5 co-authors, published in Arthritis Research & Therapy. OpenAlex counts 35 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at Arthritis Research & Therapy.
- Citations
- 35
- Most cited in
- 2025 (16)
- Field-weighted impact
- 5.68
- References
- 31
- Authors
- 6
Abstract
BACKGROUND: To compare infectious risk between JAK inhibitors (JAKis) versus TNF inhibitors (TNFis) among rheumatoid arthritis (RA) patients in Korea. METHODS: Using 2009-2019 Korea National Health Insurance Service database, we conducted a cohort study on RA patients initiating a JAKi or TNFi. The primary outcomes were herpes zoster (HZ), serious bacterial (SBI), and opportunistic infections (OI). Propensity-score fine-stratification (PSS) and weighting were applied to adjust for > 70 baseline covariates. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazard models comparing JAKi versus TNFi users. RESULTS: We included 2963 JAKi initiators PSS-weighted on 5169 TNFi initiators. During a follow-up of 1.16 years, the most frequent type of infections was HZ with incidence rate (IR) per 100 person-years of 11.54 and 4.88 in JAKi and TNFi users, respectively. The IR of SBI was 1.39 and 1.32, respectively. The OI was rare with a majority being tuberculosis and showed an IR of 0.11 and 0.49 in JAKi and TNFi users, respectively. The PSS-weighted HR (95% CI) for individual types of infections was 2.37 (2.00-2.80) for HZ, 1.04 (0.71-1.52) for SBI, and 0.25 (0.09-0.73) for OI. CONCLUSIONS: This population-based cohort study on RA patients treated with JAKi or TNFi in Korea showed an exceptionally high IR of HZ in both treatment groups compared to that from Western countries, with an approximately doubled risk associated with JAKi versus TNFi use. The risk of SBI was comparable, but the risk of OI, particularly tuberculosis, was less among JAKi than TNFi initiators.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Choi, S. R., Shin, A., Ha, Y., Lee, Y. J., Lee, E. B., & Kang, E. H. (2023). Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study. Arthritis Research & Therapy, 25(1), 129. https://doi.org/10.1186/s13075-023-03111-w
MLA 9
Choi, Se Rim, et al. “Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study.” Arthritis Research & Therapy, vol. 25, no. 1, 2023, p. 129. https://doi.org/10.1186/s13075-023-03111-w.
Chicago
Choi, Se Rim, Anna Shin, You‐Jung Ha, Yun Jong Lee, Eun Bong Lee, and Eun Ha Kang. 2023. “Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study.” Arthritis Research & Therapy 25 (1): 129. https://doi.org/10.1186/s13075-023-03111-w.
Harvard
Choi, S. R. et al. (2023) ‘Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study’, Arthritis Research & Therapy, 25(1), p. 129. doi:10.1186/s13075-023-03111-w.
IEEE
S. R. Choi, A. Shin, Y. Ha, Y. J. Lee, E. B. Lee, and E. H. Kang, “Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study,” Arthritis Research & Therapy, vol. 25, no. 1, p. 129, 2023, doi: 10.1186/s13075-023-03111-w.
BibTeX
@article{choi2023comparative,
title = {{Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study}},
author = {Choi, Se Rim and Shin, Anna and Ha, You‐Jung and Lee, Yun Jong and Lee, Eun Bong and Kang, Eun Ha},
journal = {Arthritis Research \& Therapy},
year = {2023},
volume = {25},
number = {1},
pages = {129},
doi = {10.1186/s13075-023-03111-w},
url = {https://doi.org/10.1186/s13075-023-03111-w}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 1 | |
| 2024 | 8 | |
| 2025 | 16 | |
| 2026 | 10 |
Its field-weighted citation impact is 5.68: it has been cited 5.68 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- rheumatoid arthritis
- JAK inhibitors
- TNF-alpha inhibitors
- infection risk
- herpes zoster
- serious bacterial infection
- opportunistic infections
- tuberculosis
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Choi, S. R., Shin, A., Ha, Y., Lee, Y. J., Lee, E. B., & Kang, E. H. (2023). Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study. Arthritis Research & Therapy, 25(1), 129. https://doi.org/10.1186/s13075-023-03111-w
How many times has this paper been cited?
35 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Arthritis Research & Therapy: sign in and open the PDF from this page.
Who wrote this paper?
Se Rim Choi, Anna Shin, You‐Jung Ha, Yun Jong Lee, Eun Bong Lee, Eun Ha Kang.
What is the DOI of this paper?
10.1186/s13075-023-03111-w, permanently at https://doi.org/10.1186/s13075-023-03111-w. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.